Close
Back to CGIX Stock Lookup

Cancer Genetics (CGIX) – Globe Newswire

Mar 31, 2021 06:30 AM Cancer Genetics and StemoniX Announce Merger Closing
Mar 31, 2021 06:30 AM Cancer Genetics and StemoniX Announce Merger Closing
Mar 25, 2021 09:15 AM Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
Mar 25, 2021 09:15 AM Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
Mar 18, 2021 08:30 AM Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development
Mar 18, 2021 08:30 AM Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development
Mar 12, 2021 09:30 AM Cancer Genetics to Present at the Annual 33rd ROTH Conference
Mar 12, 2021 09:30 AM Cancer Genetics to Present at the Annual 33rd ROTH Conference
Mar 4, 2021 04:15 PM Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference
Mar 4, 2021 04:15 PM Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference
Feb 16, 2021 04:45 PM Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
Feb 16, 2021 04:45 PM Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
Feb 10, 2021 11:00 PM Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
Feb 10, 2021 11:00 PM Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
Feb 1, 2021 05:16 PM Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market
Feb 1, 2021 05:16 PM Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market
Jan 28, 2021 04:01 PM Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market
Jan 28, 2021 04:01 PM Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market
Jan 7, 2021 04:05 PM Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright
Jan 7, 2021 04:05 PM Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright
Nov 12, 2020 04:25 PM Cancer Genetics Reports Third Quarter 2020 Financial Results
Nov 12, 2020 04:25 PM Cancer Genetics Reports Third Quarter 2020 Financial Results
Nov 2, 2020 04:00 PM Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
Nov 2, 2020 04:00 PM Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares
Oct 28, 2020 09:55 PM Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million
Oct 28, 2020 09:55 PM Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million
Oct 28, 2020 05:54 PM Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering
Oct 28, 2020 05:53 PM Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering
Sep 10, 2020 08:00 AM Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference
Sep 10, 2020 08:00 AM Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference
Sep 3, 2020 08:00 AM Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program
Sep 3, 2020 08:00 AM Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program
Aug 24, 2020 08:00 AM Cancer Genetics and StemoniX Sign Definitive Agreement to Merge
Aug 24, 2020 08:00 AM Cancer Genetics and StemoniX Sign Definitive Agreement to Merge
Aug 14, 2020 07:30 AM Cancer Genetics Reports Second Quarter 2020 Financial Results
Aug 14, 2020 07:30 AM Cancer Genetics Reports Second Quarter 2020 Financial Results
Jun 24, 2020 05:30 PM Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates
Jun 24, 2020 05:30 PM Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates
Jun 1, 2020 08:00 AM Cancer Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Strategic Business Updates
Jun 1, 2020 08:00 AM Cancer Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Strategic Business Updates
Feb 20, 2020 09:00 AM Cancer Genetics Issues Letter to Shareholders
Feb 20, 2020 09:00 AM Cancer Genetics Issues Letter to Shareholders
Nov 20, 2019 08:00 AM Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update
Nov 20, 2019 08:00 AM Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update
Oct 24, 2019 04:15 PM Cancer Genetics, Inc. Announces Strategic Transactions
Oct 24, 2019 04:15 PM Cancer Genetics, Inc. Announces Strategic Transactions
Oct 24, 2019 08:30 AM Cancer Genetics Announces 1-for-30 Reverse Stock Split
Oct 24, 2019 08:30 AM Cancer Genetics Announces 1-for-30 Reverse Stock Split
Oct 17, 2019 06:55 AM Interpace Announces Closing of $13 Million Second Tranche Acquisition Financing from Ampersand Capital Partners
Aug 20, 2019 08:00 AM Cancer Genetics Reports Second Quarter 2019 Financial Results and Provides Strategic Business Update

Back to CGIX Stock Lookup